Fig. 1From: TMEM16A as a potential treatment target for head and neck cancerThe Cancer Genome Atlas database (http://cancergenome.nih.gov/) showed that TMEM16A-altered head and neck cancer was significantly correlated with shorter (A) overall (p = 0.0378) and (B) disease-specific survival rates (p = 0.0483) in patients who underwent surgeryBack to article page